3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall StreetThe Motley Fool • 04/28/24
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 04/26/24
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene TherapyInvestors Business Daily • 04/26/24
U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BBusiness Wire • 04/26/24
Dividend Harvesting Portfolio Week 164: $16,400 Allocated, $1,466.94 In Projected DividendsSeeking Alpha • 04/25/24
European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsBusiness Wire • 04/22/24